Estrogen Therapy in 2017-Reference-Cited by-同舟云学术

Estrogen Therapy in 2017

Published:2017-01 Issue:1 Volume:11 Page:
ISSN:1932-9520
Container-title:Current Cardiovascular Risk Reports
language:en
Short-container-title:Curr Cardiovasc Risk Rep

Author:

Sylvestre Nastassia,Kim Catherine

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s12170-017-0527-8.pdf

Reference46 articles.

1. Sprague B, Trentham-Dietz A, Cronin K. A sustained decline in postmenopausal hormone use: results from the national health and nutrition examination survey, 1999–2010. J Obstet Gynecol. 2012;120(3):595–603.

2. Manson J, Chlebowski R. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women’s health initiative randomized trials. JAMA. 2013;310(13):1353–68.

3. Anderson G, Limacher M. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women’s health initative randomized controlled trial. JAMA. 2004;294(14):1701–12.

4. Rossouw J, Anderson G, Prentice R. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initative randomized controlled trial. JAMA. 2002;288:321–33.

5. Brunner R, Aragakl A, Barnabel V, Cochrane B, Gass M, Hendrix S, et al. Menopausal symptom experience before and after stopping estrogen therapy in the women’s health initiative randomized placebo-controlled trial. Menopause. 2010;17(5):946–54.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of menopausal symptoms on women’s daily life activities;Menopausal Review;2023